Background Suspicion of skeletal dysplasias subsequent to the detection of significant shortening of fetal long bones can pose a diagnostic dilemma as accurate diagnosis before birth can be challenging in the absence of a family history. Targeted molecular diagnosis is the most reliable approach, but this requires invasive testing and a high level of suspicion of the underlying pathology following detailed ultrasound examination to allow for targeted molecular analysis. The advent of non-invasive prenatal diagnosis using cell free fetal DNA (cffDNA) combined with expert ultrasound offers the potential for a safe, reliable approach to diagnosis in some conditions. Here the authors describe the non-invasive approach to the diagnosis of achondroplasia.
Methods All cases of achondroplasia seen in our fetal medicine units were identified, ultrasound findings and measurements ascertained. Since 2007 the Regional Genetics Laboratory at GOSH has offered cffDNA testing in selected cases. All those referred for diagnosis of achondroplasia were ascertained and cffDNA results compared with outcome at birth.
Results Fetal size charts were constructed serial measurements from 16 fetuses with Achondroplasia and frequency of sonographic features correlated with gestation. cffDNA analysis correctly confirmed the diagnosis of Achondroplasia in three fetuses and excluded it in a fourth. Fetal size charts and associated abnormities will be presented.
Conclusion Using a combination of ultrasound features and reference to size charts for fetuses with achondroplasia together with analysis of cffDNA can offer safe, accurate prenatal diagnosis in this condition.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.